Stephen Toor
Corporate Officer/Principal bei PHARMING GROUP N.V.
Vermögen: 175 912 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Stephen Toor
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Other | 25 | |
| Public Company | Pharmaceuticals: Major | 19 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stephen Toor
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal Chairman Corporate Officer/Principal | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| MEDICIS PHARMACEUTICAL CORP | Pharmaceuticals: Major | Chief Operating Officer President Chairman Sales & Marketing | |
| Rochester Christian University | College/University | Graduate Degree | |
| BAYER AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
OraPharma, Inc.
 OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | President Chairman | |
ValueAct Capital Management LP
 ValueAct Capital Management LP Investment ManagersFinance ValueAct Capital Management LP (ValueAct Capital) is a registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 2000 by Jeffrey Ubben, Peter Kamin and George Hamel. They are a subsidiary of ValueAct Holdings II LP, which is owned by Affiliated Managers Group, Inc. (NYSE: AMG). ValueAct Capital provides discretionary investment advice and management services to private investment funds and certain other investment vehicles (that include, but are not limited to, separately managed accounts and special purpose vehicles). | Investment Managers | Founder Chief Executive Officer Portfolio Manager-Equities | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
MedCore AB
 MedCore AB Medical SpecialtiesHealth Technology MedCore AB operates as a medical technology company. It engages in the distribution of medical products. The company was founded in 2000 and is headquartered in Kista, Sweden. | Medical Specialties | Chairman | |
| ENDO INTERNATIONAL PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Executive Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
| Stanford University | College/University | Masters Business Admin Graduate Degree | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman | |
| MEDA AB | Pharmaceuticals: Major | Chief Executive Officer | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| State University of New York College at Brockport | College/University | Undergraduate Degree | |
| The University of New South Wales | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Lund | College/University | Masters Business Admin | |
| Erasmus University Rotterdam | College/University | Graduate Degree | |
| University of Utrecht | College/University | Graduate Degree Doctorate Degree | |
| SYNERGETICS USA INC | Medical Specialties | President Director of Finance/CFO | |
NYSE Euronext, Inc.
 NYSE Euronext, Inc. Financial ConglomeratesFinance NYSE Euronext operates financial markets and provides trading solutions. It offers an array of products and services in cash equities, futures, options, swaps, exchange-traded products, bonds, clearing operations, market data, commercial technology solutions and carbon trading, all designed to meet the evolving needs of investors, issuers, financial institutions and market participants. The company was founded by Jean-François Théodore in 2007 and is headquartered in New York, NY. | Financial Conglomerates | Corporate Officer/Principal | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Chairman | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Ltd.
 Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
First Dutch Capital BV
 First Dutch Capital BV Investment ManagersFinance First Dutch Capital BV is a company based in Amsterdam, Netherlands that was founded by Walter van Damme. The private company is focused on empowering human progress and is a family of companies that operate in the energy, health, and technology sectors. | Investment Managers | Corporate Officer/Principal | |
NPEX BV
 NPEX BV Internet Software/ServicesTechnology Services NPEX BV specializes in designing and operating online platforms that enable investors to trade in securities. It offers auction based online trading platforms that enable investors to buy and sell illiquid and distressed assets. The firm also serves internal markets, pre-IPOs, and IPOs. The company was founded by Adriaan M. C. Hendrikse, B. Frans van den Broek and Aernoud Dekker on February 2, 2009 and is headquartered in The Hague, the Netherlands. | Internet Software/Services | Corporate Officer/Principal | |
Covis Pharma Holdings BV
 Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chairman | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Chairman | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
| Kellogg School of Management | College/University | Masters Business Admin Graduate Degree | |
| VENUS CONCEPT INC. | Medical Specialties | President Chief Executive Officer | |
| BAUSCH + LOMB CORPORATION | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
| Asiri Skincare | Founder |
Statistik
International
| Vereinigte Staaten | 29 |
| Niederlande | 8 |
| Schweden | 5 |
| Kanada | 4 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 12 |
| Finance | 5 |
| Commercial Services | 3 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 301 |
| Corporate Officer/Principal | 123 |
| Independent Dir/Board Member | 86 |
| Chairman | 63 |
| Chief Executive Officer | 55 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Jeffrey Ubben | 46 |
| Anne Michelle Whitaker | 35 |
| Fred Eshelman | 34 |
| Laurence Paul | 32 |
| Fred Hassan | 29 |
| Leonard Kruimer | 22 |
| Rajiv De Silva | 20 |
| Deborah Jorn | 20 |
| Colleen Goggins | 20 |
| Mark Pykett | 19 |
| Jabine T. M. van der Meijs | 18 |
| John Barrie Ward | 18 |
| Richard Peters | 16 |
| Steven Baert | 16 |
- Börse
- Insiders
- Stephen Toor
- Unternehmensverbindungen
